Prognosis
EU Fails to Sway AstraZeneca to Tap U.K. Supply for Vaccines
- Call between drugmaker, EU officials ends without agreement
- Deadlock leaves bloc facing additional delays in inoculations
This article is for subscribers only.
The European Union remains at loggerheads with AstraZeneca Plc after the Anglo-Swedish drugmaker rejected demands that it take Covid-19 vaccine supplies from its U.K. factories to increase doses going to the bloc.
The origin of the dispute is Astra’s decision to prioritize Britain over the EU following a Belgian production glitch, in what Brussels claims to be a breach of contract. The two sides spoke Wednesday evening and held their ground, with another meeting expected.